Savara (SVRA) Current Assets (2010 - 2026)
Savara's (SVRA) quarterly Current Assets came in at $209.3 million in Q1 2026, up 17.93% year-on-year from $177.4 million in Q1 2025, and down 13.39% on a QoQ basis from $241.6 million in Q4 2025.
Savara (SVRA) Current Assets (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Current Assets data on file, last reported at $209.3 million in Q1 2026.
- On a quarterly basis, Current Assets rose 17.93% year-over-year to $209.3 million in Q1 2026; TTM through Mar 2026 was $209.3 million, a 17.93% increase from a year earlier, with the FY2025 full-year figure at $241.6 million, up 19.53% from the prior year.
- Current Assets for Q1 2026 stood at $209.3 million, down from $241.6 million in the prior quarter.
- Over the last five years, Current Assets for SVRA reached as high as $241.6 million in Q4 2025 and fell as low as $107.9 million in Q2 2023.
- Historically, Current Assets has averaged $161.0 million across 5 years, with a median of $151.0 million in 2025.
- Across the five-year window, Current Assets soared 33.1% in 2024 and slumped 43.37% in 2025, its largest moves.
- Year by year, Current Assets stood at $129.0 million in 2022, then grew by 28.69% to $165.9 million in 2023, then advanced by 21.81% to $202.1 million in 2024, then rose by 19.53% to $241.6 million in 2025, then fell by 13.39% to $209.3 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $209.3 million in Q1 2026, $241.6 million in Q4 2025, and $128.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | 209.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209.27 Mn |
| Dec 31, 2025 | 241.62 Mn |
| Sep 30, 2025 | 128.20 Mn |
| Jun 30, 2025 | 150.99 Mn |
| Mar 31, 2025 | 177.44 Mn |
| Dec 31, 2024 | 202.14 Mn |
| Sep 30, 2024 | 226.40 Mn |
| Jun 30, 2024 | 127.69 Mn |
| Mar 31, 2024 | 146.19 Mn |
| Dec 31, 2023 | 165.95 Mn |
| Sep 30, 2023 | 170.10 Mn |
| Jun 30, 2023 | 107.90 Mn |
| Mar 31, 2023 | 117.63 Mn |
| Dec 31, 2022 | 128.95 Mn |
| Sep 30, 2022 | 137.07 Mn |
| Jun 30, 2022 | 145.39 Mn |
| Mar 31, 2022 | 154.54 Mn |
| Dec 31, 2021 | 165.00 Mn |
| Sep 30, 2021 | 174.58 Mn |
| Jun 30, 2021 | 183.49 Mn |